Tyson Foods (TSN)
NYSEConsumer StaplesFarm ProductsSnapshot 2026-07-07
$58.80+0.09%
Close 2026-07-07 · 1-day change
Reading TSN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TSN free→NYSEConsumer StaplesFarm ProductsSnapshot 2026-07-07
Reading TSN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TSN free→QuarterlyIQ Insights · TSN
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $58.80. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $59 TSN trades at 15× p/e, in line with its 13× p/e peer median — but our blended $68 fair value sits above the price. It's a high-confidence read. Analysts target $63–$80. Not investment advice.
$63.00 – $80.00 (median $78.00) · 3 analysts · as of 2026-07-02
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 54% over what the business is worth with no growth; closing that gap needs roughly — years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $1.72/sh owner earnings.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $78.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $99.14 | — | — | Analyst | high |
| dcf fcff | 12M | $98.34 | — | — | Analyst | high |
| graham number | 12M | $67.17 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $50.19 | 10.1 | 7.07 | TTM | high |
| Peer P/FCF | 12M | $43.47 | 12.5 | 3.47 | TTM | high |
| Peer P/E | 12M | $50.81 | 13.0 | 3.90 | TTM | high |
| Peer P/S | 12M | $140.83 | 0.9 | 157.37 | TTM | high |
| PEG | 12M | $114.61 | 29.4 | 3.90 | TTM | high |
| residual income | 12M | $50.54 | — | — | TTM | high |
| Own P/E history | 12M | $57.42 | 14.7 | 3.90 | TTM | high |
| triangulated | 12M | $55.42 | 13.0 | 4.25 | Triangulated | high |
| Peer P/E | 3Y | $76.72 | 13.0 | 5.89 | Analyst | medium |
| Peer P/S | 3Y | $150.35 | 0.9 | 168.02 | Analyst | medium |
| PEG | 3Y | $173.06 | 29.4 | 5.89 | Analyst | medium |
| Own P/E history | 3Y | $86.71 | 14.7 | 5.89 | Analyst | medium |
| Peer P/E | 5Y | $80.07 | 13.0 | 6.15 | Analyst | high |
| Peer P/S | 5Y | $156.91 | 0.9 | 175.35 | Analyst | high |
| PEG | 5Y | $180.61 | 29.4 | 6.15 | Analyst | high |
| Own P/E history | 5Y | $90.50 | 14.7 | 6.15 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.